Browsing Centre for Immunobiology by Author "Talaei, M"
Now showing items 1-14 of 14
-
Cohort Profile: Longitudinal population-based study of COVID-19 in UK adults (COVIDENCE UK)
Holt, H; Relton, C; Talaei, M; Symons, J; Davies, MR; Jolliffe, DA; Vivaldi, G; Tydeman, F; Williamson, AE; Pfeffer, PE (2022) -
Correlation between post-vaccination titres of anti-Spike antibodies and protection against breakthrough SARS-CoV-2 infection in 7530 UK adults
Vivaldi, G; Jolliffe, DA; Faustini, S; Holt, H; Talaei, M; Tydeman, F; Richter, AG; Shaheen, SO; Martineau, AR (2022) -
Determinants of antibody responses to primary courses and booster doses of SARS-CoV-2 vaccines in 9,101 UK adults
Jolliffe, DA; Faustini, SE; Holt, H; Talaei, M; Vivaldi, G; Richter, AG; Shaheen, SO; Martineau, AR (2022) -
Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)
Jolliffe, DA; Faustini, SE; Holt, H; Perdek, N; Maltby, S; Talaei, M; Greenig, M; Vivaldi, G; Tydeman, F; Symons, J (2022) -
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
Talaei, M; Faustini, S; Holt, H; Jolliffe, DA; Vivaldi, G; Greenig, M; Perdek, N; Maltby, S; Bigogno, CM; Symons, J (2022) -
Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)
Jolliffe, DA; Holt, H; Greenig, M; Talaei, M; Perdek, N; Pfeffer, P; Vivaldi, G; Maltby, S; Symons, J; Barlow, NL (2022) -
Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination
Holt, H; Jolliffe, DAA; Talaei, M; Faustini, S; Vivaldi, G; Greenig, M; Richter, AGG; Lyons, RAA; Griffiths, CJJ; Kee, F (2023) -
Long-term symptom profiles after COVID-19 versus other acute respiratory infections: an analysis of data from the COVIDENCE UK study
Vivaldi, G; Pfeffer, P; Talaei, M; Basera, TJ; Shaheen, S; Martineau, ALong COVID is a well recognised, if heterogeneous, entity. Acute respiratory infections (ARIs) due to other pathogens may cause long-term symptoms, but few studies compare post-acute sequelae between SARS-CoV-2 and other ... -
Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)
Tydeman, F; Pfeffer, PE; Vivaldi, G; Holt, H; Talaei, M; Jolliffe, D; Davies, G; Lyons, RA; Griffiths, C; Kee, F (2023) -
RISK FACTORS FOR BREAKTHROUGH COVID-19 IN 14,713 UK ADULTS AFTER PRIMARY AND BOOSTER DOSES OF SARS-COV-2 VACCINES
Vivaldi, G; Jolliffe, DA; Holt, H; Talaei, M; Tydeman, F; Shaheen, SO; Martineau, AR (2022) -
Risk factors for breakthrough COVID-19 in 15,804 UK adults after primary and booster doses of SARS-CoV-2 vaccines
Vivaldi, G; Jolliffe, DA; Holt, H; Talaei, M; Tydeman, F; Shaheen, SO; Martineau, AR (2022) -
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)
Vivaldi, G; Jolliffe, DA; Holt, H; Tydeman, F; Talaei, M; Davies, GA; Lyons, RA; Griffiths, CJ; Kee, F; Sheikh, A (2022) -
VITAMIN D TO PREVENT COVID-19 OR OTHER ACUTE RESPIRATORY INFECTIONS: PHASE 3 RANDOMISED CONTROLLED TRIAL (CORONAVIT)
Jolliffe, DA; Holt, H; Talaei, M; Sheikh, A; Griffiths, CJ; Shaheen, SO; Relton, C; Martineau, AR (2022) -
Vitamin D to prevent COVID-19 or other acute respiratory infections: phase 3 randomised controlled trial (CORONAVIT)
Jolliffe, DA; Holt, H; Talaei, M; Sheikh, A; Griffiths, CJ; Shaheen, SO; Relton, C; Martineau, AR (2022)